aluates Reports

$ 0.0

Automative

Global RNA Analysis & Transcriptomic Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-2M4266

Global RNA Analysis Transcriptomic Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global RNA Analysis & Transcriptomic Market Research Report 2024

Code: QYRE-Auto-2M4266

Report

April 2024

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific Inc

Bio-Rad Laboratories Inc

Merck KGaA

Agilent Technologies Inc

F Hoffmann La Roche Ltd

Danaher Corporation

Fluidigm Corporation

Eurofins Scientific

Sequentia Biotech SL

Acobiom

GenXPro GmbH

CD Genomics

Promega Corporation

Cenix BioScience GmbH

Takara Holdings, Inc.

BioMérieux SA

LC Sciences LLC

RNA Analysis & Transcriptomic Market

The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific and Sequentia Biotech SL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.

Report Scope

The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of RNA Analysis & Transcriptomic Market Report

Report Metric	Details
Report Name	RNA Analysis & Transcriptomic Market
Segment by Type	Microarrays Sequencing Polymerase Chain Reaction RNA Interference
Segment by Application	Clinical Diagnostics Drug Discovery Toxicogenomics Comparative Transcriptomics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Analysis & Transcriptomic Market report?

Ans: The main players in the RNA Analysis & Transcriptomic Market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech SL, Acobiom, GenXPro GmbH, CD Genomics, Promega Corporation, Cenix BioScience GmbH, Takara Holdings, Inc., bioMérieux SA, LC Sciences LLC

What are the Application segmentation covered in the RNA Analysis & Transcriptomic Market report?

Ans: The Applications covered in the RNA Analysis & Transcriptomic Market report are Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics

What are the Type segmentation covered in the RNA Analysis & Transcriptomic Market report?

Ans: The Types covered in the RNA Analysis & Transcriptomic Market report are Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Microarrays

1.2.3 Sequencing

1.2.4 Polymerase Chain Reaction

1.2.5 RNA Interference

1.3 Market by Application

1.3.1 Global RNA Analysis & Transcriptomic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnostics

1.3.3 Drug Discovery

1.3.4 Toxicogenomics

1.3.5 Comparative Transcriptomics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNA Analysis & Transcriptomic Market Perspective (2019-2030)

2.2 RNA Analysis & Transcriptomic Growth Trends by Region

2.2.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 RNA Analysis & Transcriptomic Historic Market Size by Region (2019-2024)

2.2.3 RNA Analysis & Transcriptomic Forecasted Market Size by Region (2025-2030)

2.3 RNA Analysis & Transcriptomic Market Dynamics

2.3.1 RNA Analysis & Transcriptomic Industry Trends

2.3.2 RNA Analysis & Transcriptomic Market Drivers

2.3.3 RNA Analysis & Transcriptomic Market Challenges

2.3.4 RNA Analysis & Transcriptomic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNA Analysis & Transcriptomic Players by Revenue

3.1.1 Global Top RNA Analysis & Transcriptomic Players by Revenue (2019-2024)

3.1.2 Global RNA Analysis & Transcriptomic Revenue Market Share by Players (2019-2024)

3.2 Global RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by RNA Analysis & Transcriptomic Revenue

3.4 Global RNA Analysis & Transcriptomic Market Concentration Ratio

3.4.1 Global RNA Analysis & Transcriptomic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis & Transcriptomic Revenue in 2023

3.5 RNA Analysis & Transcriptomic Key Players Head office and Area Served

3.6 Key Players RNA Analysis & Transcriptomic Product Solution and Service

3.7 Date of Enter into RNA Analysis & Transcriptomic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Analysis & Transcriptomic Breakdown Data by Type

4.1 Global RNA Analysis & Transcriptomic Historic Market Size by Type (2019-2024)

4.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2025-2030)

5 RNA Analysis & Transcriptomic Breakdown Data by Application

5.1 Global RNA Analysis & Transcriptomic Historic Market Size by Application (2019-2024)

5.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America RNA Analysis & Transcriptomic Market Size (2019-2030)

6.2 North America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America RNA Analysis & Transcriptomic Market Size by Country (2019-2024)

6.4 North America RNA Analysis & Transcriptomic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNA Analysis & Transcriptomic Market Size (2019-2030)

7.2 Europe RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe RNA Analysis & Transcriptomic Market Size by Country (2019-2024)

7.4 Europe RNA Analysis & Transcriptomic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNA Analysis & Transcriptomic Market Size (2019-2030)

8.2 Asia-Pacific RNA Analysis & Transcriptomic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2019-2024)

8.4 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNA Analysis & Transcriptomic Market Size (2019-2030)

9.2 Latin America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America RNA Analysis & Transcriptomic Market Size by Country (2019-2024)

9.4 Latin America RNA Analysis & Transcriptomic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNA Analysis & Transcriptomic Market Size (2019-2030)

10.2 Middle East & Africa RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2019-2024)

10.4 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific, Inc.

11.1.1 Thermo Fisher Scientific, Inc. Company Detail

11.1.2 Thermo Fisher Scientific, Inc. Business Overview

11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Introduction

11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.1.5 Thermo Fisher Scientific, Inc. Recent Development

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Bio-Rad Laboratories, Inc. Company Detail

11.2.2 Bio-Rad Laboratories, Inc. Business Overview

11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Introduction

11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.2.5 Bio-Rad Laboratories, Inc. Recent Development

11.3 Merck KGaA

11.3.1 Merck KGaA Company Detail

11.3.2 Merck KGaA Business Overview

11.3.3 Merck KGaA RNA Analysis & Transcriptomic Introduction

11.3.4 Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.3.5 Merck KGaA Recent Development

11.4 Agilent Technologies, Inc.

11.4.1 Agilent Technologies, Inc. Company Detail

11.4.2 Agilent Technologies, Inc. Business Overview

11.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Introduction

11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.4.5 Agilent Technologies, Inc. Recent Development

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Detail

11.5.2 F. Hoffmann-La Roche Ltd. Business Overview

11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Introduction

11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.5.5 F. Hoffmann-La Roche Ltd. Recent Development

11.6 Danaher Corporation

11.6.1 Danaher Corporation Company Detail

11.6.2 Danaher Corporation Business Overview

11.6.3 Danaher Corporation RNA Analysis & Transcriptomic Introduction

11.6.4 Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.6.5 Danaher Corporation Recent Development

11.7 Fluidigm Corporation

11.7.1 Fluidigm Corporation Company Detail

11.7.2 Fluidigm Corporation Business Overview

11.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Introduction

11.7.4 Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.7.5 Fluidigm Corporation Recent Development

11.8 Eurofins Scientific

11.8.1 Eurofins Scientific Company Detail

11.8.2 Eurofins Scientific Business Overview

11.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Introduction

11.8.4 Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.8.5 Eurofins Scientific Recent Development

11.9 Sequentia Biotech SL

11.9.1 Sequentia Biotech SL Company Detail

11.9.2 Sequentia Biotech SL Business Overview

11.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Introduction

11.9.4 Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.9.5 Sequentia Biotech SL Recent Development

11.10 Acobiom

11.10.1 Acobiom Company Detail

11.10.2 Acobiom Business Overview

11.10.3 Acobiom RNA Analysis & Transcriptomic Introduction

11.10.4 Acobiom Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.10.5 Acobiom Recent Development

11.11 GenXPro GmbH

11.11.1 GenXPro GmbH Company Detail

11.11.2 GenXPro GmbH Business Overview

11.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Introduction

11.11.4 GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.11.5 GenXPro GmbH Recent Development

11.12 CD Genomics

11.12.1 CD Genomics Company Detail

11.12.2 CD Genomics Business Overview

11.12.3 CD Genomics RNA Analysis & Transcriptomic Introduction

11.12.4 CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.12.5 CD Genomics Recent Development

11.13 Promega Corporation

11.13.1 Promega Corporation Company Detail

11.13.2 Promega Corporation Business Overview

11.13.3 Promega Corporation RNA Analysis & Transcriptomic Introduction

11.13.4 Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.13.5 Promega Corporation Recent Development

11.14 Cenix BioScience GmbH

11.14.1 Cenix BioScience GmbH Company Detail

11.14.2 Cenix BioScience GmbH Business Overview

11.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Introduction

11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.14.5 Cenix BioScience GmbH Recent Development

11.15 Takara Holdings, Inc.

11.15.1 Takara Holdings, Inc. Company Detail

11.15.2 Takara Holdings, Inc. Business Overview

11.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Introduction

11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.15.5 Takara Holdings, Inc. Recent Development

11.16 bioMérieux SA

11.16.1 bioMérieux SA Company Detail

11.16.2 bioMérieux SA Business Overview

11.16.3 bioMérieux SA RNA Analysis & Transcriptomic Introduction

11.16.4 bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.16.5 bioMérieux SA Recent Development

11.17 LC Sciences LLC

11.17.1 LC Sciences LLC Company Detail

11.17.2 LC Sciences LLC Business Overview

11.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Introduction

11.17.4 LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2019-2024)

11.17.5 LC Sciences LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific Inc

Bio-Rad Laboratories Inc

Merck KGaA

Agilent Technologies Inc

F Hoffmann La Roche Ltd

Danaher Corporation

Fluidigm Corporation

Eurofins Scientific

Sequentia Biotech SL

Acobiom

GenXPro GmbH

CD Genomics

Promega Corporation

Cenix BioScience GmbH

Takara Holdings, Inc.

BioMérieux SA

LC Sciences LLC

List of Tables

Table 1. Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Microarrays

Table 3. Key Players of Sequencing

Table 4. Key Players of Polymerase Chain Reaction

Table 5. Key Players of RNA Interference

Table 6. Global RNA Analysis & Transcriptomic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global RNA Analysis & Transcriptomic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global RNA Analysis & Transcriptomic Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global RNA Analysis & Transcriptomic Market Share by Region (2019-2024)

Table 10. Global RNA Analysis & Transcriptomic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global RNA Analysis & Transcriptomic Market Share by Region (2025-2030)

Table 12. RNA Analysis & Transcriptomic Market Trends

Table 13. RNA Analysis & Transcriptomic Market Drivers

Table 14. RNA Analysis & Transcriptomic Market Challenges

Table 15. RNA Analysis & Transcriptomic Market Restraints

Table 16. Global RNA Analysis & Transcriptomic Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global RNA Analysis & Transcriptomic Market Share by Players (2019-2024)

Table 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2023)

Table 19. Ranking of Global Top RNA Analysis & Transcriptomic Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by RNA Analysis & Transcriptomic Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players RNA Analysis & Transcriptomic Product Solution and Service

Table 23. Date of Enter into RNA Analysis & Transcriptomic Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global RNA Analysis & Transcriptomic Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2019-2024)

Table 27. Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2025-2030)

Table 29. Global RNA Analysis & Transcriptomic Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2019-2024)

Table 31. Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2025-2030)

Table 33. North America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific RNA Analysis & Transcriptomic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)

Table 48. Thermo Fisher Scientific, Inc. Company Detail

Table 49. Thermo Fisher Scientific, Inc. Business Overview

Table 50. Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Product

Table 51. Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 52. Thermo Fisher Scientific, Inc. Recent Development

Table 53. Bio-Rad Laboratories, Inc. Company Detail

Table 54. Bio-Rad Laboratories, Inc. Business Overview

Table 55. Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Product

Table 56. Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 57. Bio-Rad Laboratories, Inc. Recent Development

Table 58. Merck KGaA Company Detail

Table 59. Merck KGaA Business Overview

Table 60. Merck KGaA RNA Analysis & Transcriptomic Product

Table 61. Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 62. Merck KGaA Recent Development

Table 63. Agilent Technologies, Inc. Company Detail

Table 64. Agilent Technologies, Inc. Business Overview

Table 65. Agilent Technologies, Inc. RNA Analysis & Transcriptomic Product

Table 66. Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 67. Agilent Technologies, Inc. Recent Development

Table 68. F. Hoffmann-La Roche Ltd. Company Detail

Table 69. F. Hoffmann-La Roche Ltd. Business Overview

Table 70. F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Product

Table 71. F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 72. F. Hoffmann-La Roche Ltd. Recent Development

Table 73. Danaher Corporation Company Detail

Table 74. Danaher Corporation Business Overview

Table 75. Danaher Corporation RNA Analysis & Transcriptomic Product

Table 76. Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 77. Danaher Corporation Recent Development

Table 78. Fluidigm Corporation Company Detail

Table 79. Fluidigm Corporation Business Overview

Table 80. Fluidigm Corporation RNA Analysis & Transcriptomic Product

Table 81. Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 82. Fluidigm Corporation Recent Development

Table 83. Eurofins Scientific Company Detail

Table 84. Eurofins Scientific Business Overview

Table 85. Eurofins Scientific RNA Analysis & Transcriptomic Product

Table 86. Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 87. Eurofins Scientific Recent Development

Table 88. Sequentia Biotech SL Company Detail

Table 89. Sequentia Biotech SL Business Overview

Table 90. Sequentia Biotech SL RNA Analysis & Transcriptomic Product

Table 91. Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 92. Sequentia Biotech SL Recent Development

Table 93. Acobiom Company Detail

Table 94. Acobiom Business Overview

Table 95. Acobiom RNA Analysis & Transcriptomic Product

Table 96. Acobiom Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 97. Acobiom Recent Development

Table 98. GenXPro GmbH Company Detail

Table 99. GenXPro GmbH Business Overview

Table 100. GenXPro GmbH RNA Analysis & Transcriptomic Product

Table 101. GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 102. GenXPro GmbH Recent Development

Table 103. CD Genomics Company Detail

Table 104. CD Genomics Business Overview

Table 105. CD Genomics RNA Analysis & Transcriptomic Product

Table 106. CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 107. CD Genomics Recent Development

Table 108. Promega Corporation Company Detail

Table 109. Promega Corporation Business Overview

Table 110. Promega Corporation RNA Analysis & Transcriptomic Product

Table 111. Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 112. Promega Corporation Recent Development

Table 113. Cenix BioScience GmbH Company Detail

Table 114. Cenix BioScience GmbH Business Overview

Table 115. Cenix BioScience GmbH RNA Analysis & Transcriptomic Product

Table 116. Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 117. Cenix BioScience GmbH Recent Development

Table 118. Takara Holdings, Inc. Company Detail

Table 119. Takara Holdings, Inc. Business Overview

Table 120. Takara Holdings, Inc. RNA Analysis & Transcriptomic Product

Table 121. Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 122. Takara Holdings, Inc. Recent Development

Table 123. bioMérieux SA Company Detail

Table 124. bioMérieux SA Business Overview

Table 125. bioMérieux SA RNA Analysis & Transcriptomic Product

Table 126. bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 127. bioMérieux SA Recent Development

Table 128. LC Sciences LLC Company Detail

Table 129. LC Sciences LLC Business Overview

Table 130. LC Sciences LLC RNA Analysis & Transcriptomic Product

Table 131. LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)

Table 132. LC Sciences LLC Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global RNA Analysis & Transcriptomic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global RNA Analysis & Transcriptomic Market Share by Type: 2023 VS 2030

Figure 3. Microarrays Features

Figure 4. Sequencing Features

Figure 5. Polymerase Chain Reaction Features

Figure 6. RNA Interference Features

Figure 7. Global RNA Analysis & Transcriptomic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global RNA Analysis & Transcriptomic Market Share by Application: 2023 VS 2030

Figure 9. Clinical Diagnostics Case Studies

Figure 10. Drug Discovery Case Studies

Figure 11. Toxicogenomics Case Studies

Figure 12. Comparative Transcriptomics Case Studies

Figure 13. RNA Analysis & Transcriptomic Report Years Considered

Figure 14. Global RNA Analysis & Transcriptomic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global RNA Analysis & Transcriptomic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global RNA Analysis & Transcriptomic Market Share by Region: 2023 VS 2030

Figure 17. Global RNA Analysis & Transcriptomic Market Share by Players in 2023

Figure 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by RNA Analysis & Transcriptomic Revenue in 2023

Figure 20. North America RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America RNA Analysis & Transcriptomic Market Share by Country (2019-2030)

Figure 22. United States RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe RNA Analysis & Transcriptomic Market Share by Country (2019-2030)

Figure 26. Germany RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific RNA Analysis & Transcriptomic Market Share by Region (2019-2030)

Figure 34. China RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America RNA Analysis & Transcriptomic Market Share by Country (2019-2030)

Figure 42. Mexico RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa RNA Analysis & Transcriptomic Market Share by Country (2019-2030)

Figure 46. Turkey RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Thermo Fisher Scientific, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 50. Merck KGaA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 52. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 53. Danaher Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 54. Fluidigm Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 55. Eurofins Scientific Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 56. Sequentia Biotech SL Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 57. Acobiom Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 58. GenXPro GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 59. CD Genomics Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 60. Promega Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 61. Cenix BioScience GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 62. Takara Holdings, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 63. bioMérieux SA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 64. LC Sciences LLC Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions